We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$171B
1-Year Est. Return
24.68%
This Fund
S&P 500
This Quarter
Est. Return
+14.14%
1 Year Est. Return
+24.68%
3 Year Est. Return
+62.17%
5 Year Est. Return
+55.89%
10 Year Est. Return
+171.9%
AUM
$171B
AUM Growth
+$23.7B
(+16%)
Cap. Flow
+$6.93B
Cap. Flow
% of AUM
4.05%
Top 10 Holdings %
Top 10 Hldgs %
41.66%
Holding
4,427
New
337
Increased
2,605
Reduced
1,239
Closed
133
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$682M |
| 2 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$526M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$504M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$431M |
| 5 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$239M |
| 2 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$74.4M |
| 3 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$41.1M |
| 4 |
Honeywell
HON
|
+$39.3M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$38.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 73.8% |
| 2 | Technology | 9.57% |
| 3 | Financials | 3.79% |
| 4 | Industrials | 2.49% |
| 5 | Healthcare | 2.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCHW
4101
PUT
Charles Schwab
SCHW
$189B
| $59.5K | ﹤0.01% |
20,000
| – | – |
|
4102
Arq
ARQ
$100M
| $58.9K | ﹤0.01% |
+23,104
| New | +$57.3K |
|
|
INV
4103
Innventure Inc
INV
$93.9M
| $58.5K | ﹤0.01% |
11,547
-1,644
| -12% | -$9.67K |
|
|
NAGE
4104
Niagen Bioscience
NAGE
$251M
| $58.2K | ﹤0.01% |
18,254
-64,283
| -78% | -$261K |
|
4105
MicroSectors Energy -3x Inverse Leveraged ETNs
WTID
$440K
| $58.2K | ﹤0.01% |
10,000
| – | – |
|
4106
Solid Power
SLDP
$575M
| $57.1K | ﹤0.01% |
22,061
+248
| +1% | +$766 |
|
|
RCS
4107
PIMCO Strategic Income Fund
RCS
$245M
| $56.8K | ﹤0.01% |
10,431
-423
| -4% | -$2.29K |
|
4108
Ovid Therapeutics
OVID
$547M
| $56.5K | ﹤0.01% |
+20,998
| New | +$54.2K |
|
4109
TechTarget
TTGT
$293M
| $56.2K | ﹤0.01% |
15,598
+4,819
| +45% | +$22.1K |
|
4110
Holley
HLLY
$370M
| $55.2K | ﹤0.01% |
21,653
-84,398
| -80% | -$239K |
|
|
MMT
4111
Aberdeen Multi-Market Income Fund
MMT
$243M
| $54.2K | ﹤0.01% |
+12,310
| New | +$55.7K |
|
|
HIVE
4112
HIVE Digital Technologies
HIVE
$853M
| $53.8K | ﹤0.01% |
14,775
-1,676
| -10% | -$5.42K |
|
|
EVF
4113
Eaton Vance Senior Income Trust
EVF
$89.8M
| $52.9K | ﹤0.01% |
10,631
-9,540
| -47% | -$47.5K |
|
|
RZLV
4114
Rezolve AI
RZLV
$921M
| $51.8K | ﹤0.01% |
16,453
-11,652
| -41% | -$30.7K |
|
4115
PUT
Microsoft
MSFT
$3.71T
| $51.3K | ﹤0.01% |
+3,500
| New | +$1.42M |
|
4116
Outset Medical
OM
$67.5M
| $51K | ﹤0.01% |
+11,795
| New | +$51.6K |
|
4117
PUT
Abbott
ABT
$187B
| $50.7K | ﹤0.01% |
+6,900
| New | +$630K |
|
|
ECC
4118
Eagle Point Credit Company
ECC
$521M
| $50.6K | ﹤0.01% |
13,594
-2,891
| -18% | -$11.5K |
|
4119
Quantum-Si Incorporated
QSI
$168M
| $49.5K | ﹤0.01% |
55,884
+3,336
| +6% | +$3.18K |
|
4120
Village Farms International
VFF
$357M
| $49K | ﹤0.01% |
24,502
+11,900
| +94% | +$29.8K |
|
4121
Galectin Therapeutics
GALT
$465M
| $48.9K | ﹤0.01% |
10,539
+54
| +0.5% | +$140 |
|
4122
CALL
Lockheed Martin
LMT
$121B
| $47K | ﹤0.01% |
+1,200
| New | +$649K |
|
4123
Cricut
CRCT
$1.16B
| $46.7K | ﹤0.01% |
+10,630
| New | +$45.5K |
|
|
BLNE
4124
Beeline Holdings
BLNE
$35.2M
| $46.6K | ﹤0.01% |
38,175
| – | – |
|
4125
Atlas Lithium Corp
ATLX
$100M
| $46.2K | ﹤0.01% |
12,525
| – | – |
|
Similar funds
Creative Planning's Q2 2026 Portfolio in Review
As of Q2 2026, Creative Planning held 4,427 positions worth $171B, up 16% from $147B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Creative Planning deployed $6.93B of net new capital in Q2 2026, opening 337 new positions and adding to 2,605 existing holdings. Its largest new stake was Honeywell Aerospace: 169,880 shares worth $37.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 74% of assets, down from 76% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $239M trimmed.
- Creative Planning's largest Q2 2026 buy was Honeywell Aerospace: 169,880 shares worth $37.6M.
- Creative Planning added most to Vanguard Total Bond Market in Q2 2026, an estimated $682M increase.
- Creative Planning's biggest Q2 2026 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $239M.
- Creative Planning fully exited Hologic in Q2 2026, selling an estimated $8.29M.
- Creative Planning's ten largest holdings make up 42% of its $171B portfolio in Q2 2026.
- Creative Planning opened 337 new positions and closed 133 in Q2 2026.
- Creative Planning's portfolio value rose 16% quarter-over-quarter to $171B.
Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.